Nepali Drug Manufacturers Demand Protection Against Imports
Summary
Nepali drug manufacturers are urging the government to restrict imports of finished medicines to protect domestic industries operating at reduced capacity and facing closure risks, advocating import of only raw materials to reduce production costs.
Key Points
- Nepali drug manufacturers demand government restrictions on imported finished medicines to protect local industries.
- Approximately 100 drug industries exist in Nepal, with many struggling or closed due to import competition.
- Domestic industries operate at 20-40% capacity, producing about 80% of national medicine demand if fully utilized.
- Manufacturers request customs duty exemptions on packaging and technology imports to reduce production costs.
